Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dexcom Inc (NQ: DXCM )

70.35 -0.13 (-0.18%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dexcom Inc

< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
Crude Oil Down Over 2%; Bristol Myers Squibb Posts Upbeat Q2 Results
Via Benzinga
Exposures Fossil Fuels
DexCom Faces Short-Term Challenges, But Market Growth Prospects Remain Strong: Analyst
DexCom reports Q2 sales of $1.004B, up 15% YoY, with adjusted EPS of $0.43, beating the $0.39 consensus. Despite lowering 2024 sales guidance to $4.00-$4.05B, William Blair maintains an Outperform... 
Via Benzinga
Why DexCom Stock Is Crashing Today
Investors are worried about the diabetes care technology leader's slowing growth. 
Via The Motley Fool
Why DexCom Stock Is Trading Lower Friday
DexCom shares are trading lower Friday after the company reported worse-than-expected second quarter revenue and issued weak guidance. 
Via Benzinga
Kroger and Albertsons Pause Merger Deal: KR and ACI Stocks on Watch
Kroger and Albertsons are gearing up for a Colorado lawsuit that has put the combination of the two grocery companies on hold. 
Via InvestorPlace
Topics Lawsuit
Exposures Financial Legal
$100 Invested In DexCom 10 Years Ago Would Be Worth This Much Today
Via Benzinga
NASDAQ:DXCM: a strong growth stock preparing for the next leg up?.
DEXCOM INC (NASDAQ:DXCM): a strong growth stock preparing for the next leg up?. 
Via Chartmill
Stock Market Diverges, With Tesla, Google, ServiceNow, GE In Focus: Weekly Review
Small caps continued to lead, while the Nasdaq broke below key levels. 
Via Investor's Business Daily
Dexcom (DXCM) Stock Is Plunging on an ‘Execution Miss.’ What Is Really Going On?
Dexcom's Stelo faces an uncertain future thanks to drugs like Wegovy and a competing Abbott Labs product. DXCM stock is down 40% today. 
Via InvestorPlace
LTM Stock IPO: 7 Things to Know as LATAM Airlines Returns to the NYSE
LATAM Airlines stock is back on the NYSE alongside an IPO for LTM shares after they were delisted from the market back in 2020. 
Via InvestorPlace
Topics Initial Public Offering
Exposures Securities Market
Why Is Zynex (ZYXI) Stock Down 24% Today?
Zynex stock is falling on Friday as ZYXI investor react to earnings misses and poor guidance for Q3 and the full year of 2024. 
Via InvestorPlace
Topics Earnings
Exposures Financial
Why Is DexCom (DXCM) Stock Down 38% Today?
DexCom stock is up on Friday as DXCM investors react to the company's latest earnings report and its lackluster 2024 guidance. 
Via InvestorPlace
DexCom, Zynex, Olin And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
This Southwest Airlines Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Via Benzinga
Dexcom Shares Plummet Nearly 39% In Pre-Market After Lowering Full-Year Sales Outlook
During an analyst call, Dexcom executives attributed the forecast cut to fewer new customers and lower revenue per customer than expected. 
Via Benzinga
US Stocks Look To End Week On High Note As Nvidia Leads Mega-Caps Higher In Premarket Ahead Of Key Inflation Data
After the severe pounding the tech space received in the past three sessions, it might be rebound time. However, any recovery will largely hinge on whether key inflation data confirms the continued... 
Via Benzinga
Topics Economy
Exposures Interest Rates
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Pre-market stock movers are worth diving into this morning as we check out all of the hottest news investors need to know about on Friday! 
Via InvestorPlace
Why Is Omnipod Insulin Device Maker Insulet Stock Jumping Today?
Insulet Corporation shares are rising after the company reported stronger-than-expected second-quarter revenue, driven by high demand for Omnipod 5 and a raised full-year revenue outlook. 
Via Benzinga
Get Your Money Out of These 3 Nasdaq Stocks by the End of July
Discover why these three Nasdaq stocks may be worth selling at their current price levels. 
Via InvestorPlace
Why Ultra Clean Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
Via Benzinga
DexCom (DXCM) Q2 2024 Earnings Call Transcript
DXCM earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Walt Disney, Eli Lilly, AST SpaceMobile, DexCom, Tesla: Why These 5 Stocks Are On Investors' Radars Today
On Thursday, major U.S. indices showed mixed results. The Dow Jones Industrial Average increased by 0.2% to 39,935.07. 
Via Benzinga
Topics Stocks
Exposures US Equities
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of DexCom, Inc. (DXCM) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
DXCM Stock Earnings: DexCom Beats EPS, Misses Revenue for Q2 2024
DXCM stock results show that DexCom beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Dexcom Stock Collapses 33% After Sales Miss Leads To $25 Million Guidance Cut
Shares are poised to open Friday at their lowest point since April 2022. 
Via Investor's Business Daily
Topics Earnings
Exposures Financial
Nasdaq 100 Falls To 7-Week Lows, Marks Worst 2-Day Drop In Nearly 2 Years As Tech Rout Rages On
Nasdaq 100 index falls to its lowest level since June amid volatility. Despite a brief boost from Q2 GDP growth and decreasing prices, it dropped 4.7% in 2 sessions. 
Via Benzinga
DexCom Stock Drops After Mixed Q2 Results, Weak Forward Guidance
DexCom shares are dropping after the company reported its second-quarter financial results Thursday. Here's a look at the key figures from the report. 
Via Benzinga
Dexcom Reports Second Quarter 2024 Financial Results, Updates Guidance, and Announces $750 Million Share Repurchase Program
From DexCom, Inc.
Via Business Wire
Abbott Labs Makes Marketing Push For New Glucose Monitors, Targets Health-Conscious Consumers
Abbott Laboratories is launching Lingo, an over-the-counter glucose monitoring device aimed at non-diabetic consumers, utilizing TV and guerilla marketing. CEO Robert Ford expects Lingo to become a... 
Via Benzinga
2 Healthcare Stocks to Buy at a Discount
Beaten-down stocks can sometimes present an opportunity. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.